
|Articles|June 9, 2022
Oncology Research Veterans Launch TrialNAV
Advertisement
TrialNAV, a clinical research solutions company designed to bridge the gaps between industry sponsors, research sites, and cancer trial participants has announced its launch. The company's suite of offerings will offer solutions for the identified challenges in the pharmaceutical and technology industries, clinical research organizations, site management organizations, and clinical research sites within healthcare organizations. The solutions are designed to improve enrollment in clinical research and provide better access to treatment options for people living with cancer.
Read more about the launch
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
4
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
5



